557 related articles for article (PubMed ID: 28576386)
1. [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management].
Achargui S; Zidouh A; Abirou S; Merhfour FZ; Monsif S; Amahrouch S; El Ghobre A; El Halhali M; Temmara H; El Hryfy A; Motqi M; Satty A; Kandili M; Aghri M; Hajjout K; Benajiba M
Transfus Clin Biol; 2017 Nov; 24(4):422-430. PubMed ID: 28576386
[TBL] [Abstract][Full Text] [Related]
2. [Identification of alloantibodies and their associations: balance sheet of a year at the Auvergne-Loire French Blood Establishment].
Duboeuf S; Flourié F; Courbil R; Benamara A; Rigal E; Cognasse F; Garraud O
Transfus Clin Biol; 2012 Dec; 19(6):358-65. PubMed ID: 23159062
[TBL] [Abstract][Full Text] [Related]
3. Alloimmunization in transfused patients with constitutional anemias in Norway.
Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
[TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.
El Kababi S; Benajiba M; El Khalfi B; Hachim J; Soukri A
Transfus Clin Biol; 2019 Nov; 26(4):240-248. PubMed ID: 31279519
[TBL] [Abstract][Full Text] [Related]
5. [Transfusion management of patients with red blood cell antibodies].
Bujandrić NB; Grujić JN; Krga-Milanović MM
Med Pregl; 2013; 66(11-12):491-6. PubMed ID: 24575638
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
7. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
8. [Difficulties of the care of public antigen alloimmunization].
Ben Amor I; Rekik T; Louati N; Lahiani W; Rekik H; Peyrard T; Menif H; Gargouri J
Transfus Clin Biol; 2016 May; 23(2):103-5. PubMed ID: 26826911
[TBL] [Abstract][Full Text] [Related]
9. [Transfusion and alloimmunization in sickle cell anemia patients].
Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
[TBL] [Abstract][Full Text] [Related]
10. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
11. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
Strupp A; Cash K; Uehlinger J
Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
Cheng CK; Lee CK; Lin CK
Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
[TBL] [Abstract][Full Text] [Related]
13. Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service.
Pereira Bueno ML; Mitestainer MB; Da Silva JAR; Benites BD; Roversi FM
Transfus Clin Biol; 2021 Aug; 28(3):258-263. PubMed ID: 33901640
[TBL] [Abstract][Full Text] [Related]
14. Red cell alloantibodies in patients with haemoglobinopathies.
Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
[TBL] [Abstract][Full Text] [Related]
15. Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review.
O'Brien KL; Kim YA; Haspel RL; Uhl L
Transfusion; 2015 Mar; 55(3):599-604; quiz 598. PubMed ID: 25118004
[TBL] [Abstract][Full Text] [Related]
16. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
Thakral B; Saluja K; Sharma RR; Marwaha N
Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
[TBL] [Abstract][Full Text] [Related]
17. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
Ndahimana E; Gothot A; Gérard C; Senyana F; R'Zik S; Mukabayire O; Mutesa L
East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096
[TBL] [Abstract][Full Text] [Related]
18. [Immunohematologic study and transfusion approach to patients with public antibodies].
Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
[TBL] [Abstract][Full Text] [Related]
19. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
[TBL] [Abstract][Full Text] [Related]
20. A delayed hemolytic transfusion reaction (DHTR) with multiple alloantibodies (Anti-E, Jka, Dia, Fyb, and S) induced by E-antigen-negative, crossmatch-compatible blood.
Yamane K; Yagihashi A; Sasaki M; Kuwashima K; Morio A; Watanabe N
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):531-9. PubMed ID: 9805232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
